Loading NKIND price...
Peers are the listed companies in the exchange's own industry group: Edible Oil. Balance-sheet figures are from the latest filed balance sheet; trends show each financial year we hold.
Latest quarterIn the quarter to June 2026 (results filed 11 Aug 2026), sales fell 44.3% from a year earlier to Rs 2.1 cr and the loss was Rs 0.7 cr against Rs 0.7 cr a year earlier.
- Reported a loss in FY24 and FY25 and FY26.
- Operating margin fell from 4.7% in FY23 to -13.7% in FY26.
- Return on equity stayed under 10% from FY24 to FY26 (highest 1.0%).
Each line is written by a fixed rule from the company's own filings and share price, and names the figures it uses. It describes what happened; it is not advice about the share.
Over the last 20 results, the share rose on 14 and fell on 6, and moved by 3% or more on 11.
Q1 FY27: results filed 11 Aug 2026. The share went from its close on 10 Aug 2026 to its close on 12 Aug 2026 -5.84%.
Of every Rs 100 of sales in FY26, Rs 114 went on running costs, Rs 20 on depreciation; the year ended in a loss.
Thin bar: money in (sales plus other income). Thick bar: where it went. Each year is scaled to its own sales, so the bars compare shares, not size.
Per year, compounded, between financial years FY26 and the year named; only spans our filings cover. The faint bar is the latest quarter against the same quarter a year earlier. Earnings per share is not shown: filed figures are not adjusted for bonus issues and splits, so its growth would mislead.
| Measure | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Sales growthSales against the previous financial year. | - | 5.4% | -10.7% | 6.3% | -38.9% |
| Operating marginProfit from operations, before depreciation, interest and tax, per Rs 100 of sales. | 10.8% | 4.7% | 7.3% | -5.9% | -13.7% |
| Net marginProfit after everything, per Rs 100 of sales. | -7.4% | -7.5% | -5.2% | -17.2% | -29.0% |
| ROEProfit as a percentage of shareholders' money (from the March balance sheet). | - | 0.5% | 0.3% | 1.0% | 1.0% |
| ROCEOperating profit as a percentage of all long-term capital, owners' and lenders'. | - | -0.1% | -0.1% | -0.2% | -0.2% |
| Interest coverHow many times operating profit covers the interest bill. Higher is safer. | -19.0x | -5.5x | - | - | - |
Each row is coloured against this company's own usual level, not against other companies: green is better than its middle year, red worse, plain is close to it. ROE, ROCE and debt rows start once the filings carry a full balance sheet (FY22 at the earliest).
At FY26 it owned Rs 1,891 Cr of assets. Its owners funded 0% of that, with no borrowings.
From the March balance sheet in the company's annual filing (2026-03-31). Each bar is the full balance sheet; "everything else" is what the filed total leaves after the named lines.
In FY26 the business itself brought in Rs -0 Cr, spent Rs 0 Cr on plant and equipment, and cash rose by Rs 1 Cr over the year.
Full financial year to 2026-03-31, from the company's cash flow statement.
Median rather than average, so one loss-making or one very expensive peer cannot drag the reference. Valuation is shown without a colour verdict: a higher multiple can mean expensive, or faster growth expected, and only you can decide which.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| MARICO Marico Limited | 1.01 L cr | 53.2x | 23.9x | 43.4% | 39.0% | 0.08 | 13.6% | +21.4% | 0.98% |
| PATANJALI Patanjali Foods Limited | 37,798 cr | 19.2x | 2.9x | 15.0% | 11.3% | 0.21 | 4.6% | +27.4% | 0.70% |
| AWL AWL Agri Business Limited | 22,318 cr | 19.3x | 2.1x | 11.1% | 16.8% | 0.08 | 1.5% | +17.5% | 0.00% |
| GOKULAGRO Gokul Agro Resources Limited | 2,882 cr | 11.1x | 2.0x | 29.6% | 36.6% | 0.40 | 1.7% | +7.3% | 0.00% |
| KNAGRI KN Agri Resources Limited | 475 cr | 10.5x | 1.2x | 11.7% | 14.2% | 0.09 | 1.9% | - | 0.00% |
| GOKUL Gokul Refoils and Solvent Limited | 342 cr | 16.5x | 0.9x | 5.7% | 15.6% | 1.05 | 0.5% | +9.8% | 0.00% |
| KRITINUT Kriti Nutrients Limited | 328 cr | 9.8x | 1.4x | 14.5% | 19.4% | 0.03 | 3.5% | +7.9% | 5.00% |
| HALDER Halder Venture Limited | 274 cr | - | 1.5x | - | 28.1% | 1.97 | - | - | 0.45% |
| MKPL M K Proteins Limited | 139 cr | 28.5x | 1.8x | 6.2% | 14.3% | 0.47 | 1.2% | +0.2% | 0.00% |
| ROML Raj Oil Mills Limited | 58 cr | 13.4x | 27.1x | - | 167.0% | 11.86 | 2.9% | +5.8% | 0.00% |
| NKIND NK Industries Limited | 34 cr | - | - | 1.0% | -0.2% | - | -33.3% | -44.3% | 0.00% |
Swipe the table sideways for more columns. Tap a heading to sort. A dash means the figure is not filed or cannot be worked out for that company. A bigger cohort is cut to its 40 largest companies.
Operating margin has gone from 10.8% to -13.7% over these years - the share of every rupee of sales kept after running costs, before interest and tax. Full financial years only, so a part-year is never shown as a whole one. Hover any year for its complete figures.
| Date | Party | Side | Qty | Price | Value |
|---|---|---|---|---|---|
| 2026-10-22 | PUNEET MITTAL HUF | BUY | 52,527 | 66.82 | Rs 0.35 Cr |
| 2026-10-22 | PUNEET MITTAL HUF | SELL | 25,527 | 66.11 | Rs 0.17 Cr |
| 2026-10-21 | RIMPY MITTAL | BUY | 36,384 | 61.76 | Rs 0.22 Cr |
| 2026-10-21 | RIMPY MITTAL | SELL | 10,982 | 61.21 | Rs 0.07 Cr |
| 2026-08-21 | AMRITA JAIN | BUY | 1,05,283 | 67.42 | Rs 0.71 Cr |
| 2026-08-21 | AMRITA JAIN | SELL | 89,852 | 67.12 | Rs 0.6 Cr |
| 2026-08-21 | AGARWAL SUBHASH | SELL | 41,734 | 67.9 | Rs 0.28 Cr |
| 2026-08-21 | AGARWAL SUBHASH | BUY | 1,235 | 59.99 | Rs 0.01 Cr |
The share of traded quantity that was actually delivered (not squared off intraday) - high delivery vs its 20-session average suggests real buying or holding, not just churn.
Insider trading data unavailable.
Announcements unavailable.
Backtest an equity strategy on real market data, free - no card needed.
Equity price, fundamentals and realized volatility are end-of-day / quarterly from real market data. The option chain (PCR, max pain, expected move, IV, OI) is live from the exchange during market hours; outside them it shows the last session's close. Shareholding, insider trades and announcements are the company's own exchange filings. Analysis only, not investment advice.